| MANNKIND CORP. NEW DL-,01 |
| USA |
| Gesundheit |
| US56400P7069 / A2DMZL |
| NNFN (Frankfurt) / MNKD (NASDAQ) |
| FRA:NNFN, ETR:NNFN, NNFN:GR, NASDAQ:MNKD |
| - |
| https://mannkindcorp.com/ |
|
MannKind Corporation is a biopharmaceutical compan..
>Volltext.. |
| 1513.18 Mio. EUR |
| 1484.18 Mio. EUR |
| 271.28 Mio. EUR |
| 75.13 Mio. EUR |
| 25.27 Mio. EUR |
| 0.08 EUR |
| 195.34 Mio. EUR |
| 110.13 Mio. EUR |
| 41.68 Mio. EUR |
| 2.38 |
| 11.43% |
| 28.61% |
| - |
| - |
| - |
| - |
| MANNKIND |
| 10.11.25 |
|